[1]
Zhu, X. et al. 2026. The Clinical Utility of DWI-ADC Value in Predicting the Efficacy of TACE for Hepatocellular Carcinoma. Proceedings of the Bulgarian Academy of Sciences. 79, 5 (May 2026), 633–639. DOI:https://doi.org/10.7546/CRABS.2026.05.11.